Manufacturer record
Park Pharmaceuticals 272 Ind. Area Phase II: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by Park Pharmaceuticals 272 Ind. Area Phase II (Haryana) was declared Not of Standard Quality in October 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: AP-241242, Cefixime, Azithromycin & Lactic Acid Bacillus Tablets (CEFICO- AZ TABLETS) (exp Dec 2026). SDTL Raipur Chhattisgarh (state lab) found it not of standard quality: Assay. Listed in the October 2025 alert.
Records by type
1 record linked to Park Pharmaceuticals 272 Ind. Area Phase II in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Cefixime, Azithromycin & Lactic Acid Bacillus Tablets (CEFICO- AZ TABLETS) | Batch AP-241242Mfg Jan 2025 · Exp Dec 2026 | AssayAssay | SDTL Raipur ChhattisgarhState lab | Oct 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.